Aims To study mortality in a cohort of cocaine use disorder patients, and compare results in those with concurrent alcohol or opiates disorder. Design, Setting and Participants A cohort of 10 539 cocaine use disorder individuals entering drug treatment in public out-patient centres in the city of Barcelona was followed from 1997 to 2011. Participants were divided at baseline into three groups: those with only cocaine use disorder (CUD), those with cocaine and alcohol use disorder but not opioid (CAUD) and those with cocaine and opioid use disorder (COUD). Mortality was assessed through the Spanish National Mortality Register. Measurements Crude mortality rates (CMR), standardized mortality ratios (SMR) and rate ratios (RR) were calculated for each group. A multivariable Cox regression model was fitted to obtain adjusted mortality hazard ratios (aHR) of CAUD and COUD with respect to CUD. Specific mortality causes were also examined. Findings The total of 716 deaths registered resulted in a CMR = 6.0/1000 person-years (PY); 95% confidence interval (CI) = 5.1-7.0 for CUD, CMR = 5.8/1000 PY (95% CI = 4.9-6.7) for CAUD and CMR = 20.7/ 1000 PY (95% CI = 18.8-22.8) for COUD, with no significant differences among sexes. Compared with the general population, mortality was four times higher (SMR = 4.1, 95% CI = 3.5-4.8) among CUD, more than three times among CAUD (SMR = 3.4, 95% CI = 2.9-3.9) and more than 10 times among COUD (SMR = 11.6, 95% CI = 10.5-12.8), being always higher in women. External injuries, led by overdose, accumulated the biggest percentage of deaths among the three groups, but infectious diseases showed the highest excess mortality. Some differences regarding causes of death were observed between the three groups. Conclusions Mortality risk and excess mortality are significantly greater among those with cocaine and opiates use disorder than among people with only cocaine use disorder or cocaine and alcohol use disorder.
INTRODUCTION
Cocaine is the most commonly used illicit stimulant drug in Europe. More than 2 million people used cocaine in the last year in Europe, with Spain and the United Kingdom leading the ranking of prevalence of cocaine use [1] . Admission of cocaine users to specialized drug treatment centres started to grow in Spain in the 1990s, soon exceeding that of heroin users, which was already declining. Currently, cocaine is responsible for the greatest proportion of admissions to treatment for illegal drugs, with approximately 25% of all admissions [2] . In Barcelona, cocaine use increased up to 2006, when it reached a prevalence per 100 inhabitants of 2.50 [95% confidence interval (CI) = 1.54-4.13] among those aged 15-54 years [3] .
Despite the limited use of heroin and other opioids, these continue to be the drugs associated with most of the mortality related to illegal drug use in Europe, basically owing to drug overdose and infectious diseases [1, 4, 5] . Regarding cocaine, evidence suggests that its use increases the risk of injuries, cardiovascular disease, stroke and other health problems [6] [7] [8] [9] [10] , but available mortality rates for cocaine vary widely. According to a systematic review of cohort studies [11] , crude mortality rates among dependent cocaine users ranged from 0.53 to 6.1 per 100 person-years (PY), being four to eight times higher than their age and sex peers in the general population.
This variability in cocaine-related mortality could be attributed to the fact that cocaine users are not a homogeneous group and that the concomitant use of cocaine with other drugs, primarily opioids, would establish differences among cocaine users in the prevalence of injected use, HIV and other infectious diseases, and in the socio-economic background, that may distort mortality findings.
In order to address these issues, recent research in this field has made a distinction between socially integrated users who snort powder cocaine and who do not use heroin, and more marginalized users who use cocaine in conjunction with opiates [12] [13] [14] , recording a higher mortality risk among users of both cocaine and heroin and among those injecting drugs.
Concurrent alcohol use disorder is also common among those seeking treatment for cocaine dependence [15, 16] , with codependent patients presenting a wider array of health and social problems [16] . It has also been proposed that the synergistic effect of alcohol may potentiate acute adverse effects of cocaine [17, 18] , thus increasing mortality risks.
In order to contribute to the scant and inconclusive literature on cocaine-related mortality, the objective of this study was to estimate mortality rates and excess mortality overall and by specific causes of death in a cohort of cocaine users entering drug-dependence treatment and to compare the results in those with concurrent alcohol or opiates disorder.
METHODS

Design
A longitudinal study was designed with a dynamic cohort of 10 539 cocaine use disorder patients entering drug treatment between 1997 and 2011 in nine of the 14 public out-patient treatment centres in the city of Barcelona. These fully accessible public treatment centres with no waiting list are distributed evenly in the territory, covering different socio-economic areas, and represent 73.8% of all cocaine treatment starts in the city. Treatment is provided universally free of charge, including opiate substitution treatment if needed. To estimate differences in mortality, participants were divided into three groups considering their concomitant use of alcohol or opiates in addition to cocaine. The study had the approval of the Ethics Committee of Hospital del Mar and all participants signed an informed consent when entering the study.
Participants
The prime criterion for inclusion of participants in the study was the occurrence of cocaine use disorder, irrespective of the drug for which they initiated treatment. Participants were divided at baseline into three groups: those with only cocaine use disorder (CUD), those with alcohol use disorder in addition to cocaine (CAUD) and those with cocaine and heroin or other opioids use disorder (COUD). In cases where opioids and alcohol use disorder occurred together with cocaine, precedence was given to opioids.
Further information recorded at baseline was: sex, age, educational level, occupational status and whether or not they had a criminal record. Regarding health status, information on self-perceived health, a history of psychopathology and positive HIV status were also recorded. Drug use patterns, such as years of cocaine use and ever use of injected drugs, were also recorded.
Vital status of participants was obtained through confidential probabilistic record linkage with the Spanish National Mortality Register. In cases of death, date and cause of death were noted. Subjects not detected as dead were assumed to be still alive at the end of the study period (31 December 2011).
Statistical analysis
All-cause crude mortality rates (CMR) and 95% confidence intervals (CI) were calculated separately for the three groups of cocaine users (CUD, CAUD and COUD) and by the different socio-demographic, health and drug use pattern variables. CMR were expressed in PY of follow-up. Each subject contributed to PY from baseline (date of treatment entry) until the date of death or 31 December 2011 (end of study). Standardized mortality ratios (SMR) obtained using the indirect method and rate ratios (RR) by age groups were also computed in order to estimate excess mortality for the three user groups and by sex, using the general population of Barcelona in 2011 as the reference. SMR were also calculated, taking into account only the first year after treatment entry. Specific mortality causes were registered using the International Classification of Diseases, ninth revision (ICD-9) for 1997-98 and ICD-10 thereafter. Causes of death were grouped into broad categories (external injuries, infectious diseases, circulatory diseases, respiratory diseases, neoplasms, digestive diseases, other diseases and ill-defined); each category except other diseases and ill-defined were further divided into subcategories. Codes included in each category are shown as Supporting information (Table S1 ). CMR and RR were also calculated per cause of death for each group. Finally, a multivariable Cox regression model was fitted in order to obtain aHR and 95% CI of CAUD and COUD with respect to CUD. The proportional hazard assumption, checked by examining Schoenfeld residuals, was not violated. Data were censored at 31 December 2011. The model was adjusted for sex, age, educational level, occupational status, HIV status (unknown HIV status considered as a category) and ever injector. All analyses were performed using Stata version 10.1.
RESULTS
A total of 10 539 individuals (81% men) were followed from 1997 until their death or the end of 2011, generating a total of 71 924.5 PY of follow-up. Table 1 shows participants' descriptive characteristics at treatment entry by group of drug use disorder. CUD represented 34% of the total, CAUD 43% and COUD 23%. The proportions of women were 23, 16 and 20%, respectively. Mean age at entry was 31.6 years [standard deviation (SD) = 8.1] for CUD, 33.2 (SD = 7.9) for CAUD and 32.3 (SD = 7.2) for COUD. Approximately 55% of CUD and CAUD had completed only primary education, while among COUD the figure was 72%. Furthermore, only 20% of COUD were working at baseline, compared to approximately 55% in the other two groups. Also, almost 60% of COUD had a criminal record compared to 23% of CUD and 27% of CAUD. Regarding health status, approximately 60% of CUD and CAUD perceived their health as good, whereas among COUD the corresponding figure was 40%. Conversely, more than 30% of CUD and CAUD had a record of psychopathology, while among COUD the corresponding figure was only 18%. Differences concerning HIV infection were also substantial, with only 2-3% with positive serostatus among CUD and CAUD compared to 17% among COUD. Regarding use patterns, the highest proportions of individuals with more than 10 years of cocaine use were recorded among CAUD and COUD (44 and 45%, respectively), while CUD had the highest percentage of individuals, with fewer than 5 years of use (33%). Finally, 71% of COUD had a record of having used injected drugs compared to only 6% in the other groups.
Baseline characteristics
Mortality
A total of 716 deaths were registered in the study period, with a mean age at death of 39.3 years. CMR were 6.0/ 1000 PY for CUD, 5.8/1000 PY for CAUD and 20.7/ 1000 PY for COUD overall, with no significant differences between men and women (Table 1 ). Higher CMR were found in all groups among those categorized as disabled/pensioner, followed by unemployed and those with a criminal record. CMR were also higher among those reporting poor health and, particularly, among those with a positive HIV test (18.7/1000 PY for CUD; 33.6/1000 PY for CAUD; and 42.4/1000 PY for COUD) and for those who had ever injected drugs (16.6/1000 PY for CUD; 18.3, for CAUD; and 24.0 for COUD). Among CAUD and COUD, CMR were higher for those with more than 10 years of cocaine use. Table 2 describes CMR and RR per age group and SMR by group of drug use disorder. Compared with the general population, mortality among CUD was four times higher (SMR = 4.1), more than three times higher among CAUD (SMR = 3.4) and more than 10 times higher among COUD (SMR = 11.6). SMR for the first year after treatment entry were higher than those obtained for the entire period in the three groups (SMR = 9.2, 95% CI = 5.5-12.9 for CUD, SMR = 4.1, 95% CI = 2.0-6.2 for CAUD and SMR = 37.8, 95% CI = 28.6-46.9 for COUD). This excess mortality was always larger for women. Also, results by age group indicate that the largest contribution to excess mortality corresponded to the youngest group. Mortality RR among those aged 18-34 were 20.8 for CUD, 19.2 for CAUD and 114.8 for COUD.
The results of the Cox regression revealed that after adjusting for socio-demographic, health and use pattern variables, the risk of death among COUD was still two times higher than among CUD (aHR = 2.14, 95% CI = 1.68-2.73). Conversely, differences between CUD and CAUD were not significant (aHR = 0.85, 95% CI = 0.68-1.07). No differences by gender were observed. Table 3 displays causes of death by categories for the total cohort and by group of drug use disorder. Of the 711 deaths with a valid recorded cause, 20.7% corresponded to CUD, 22.2% to CAUD and 57.1% to COUD. The broad category accumulating the biggest percentage of deaths overall and among the three groups was external injuries (CUD = 41.5%, CAUD = 33.5% and COUD = 36.2%), with overdose also leading this category in the three groups, with 16.3, 13.3 and 22.7% of all deaths, respectively. However, while other external injuries was the second most common specific cause of death for CUD and CAUD, (Table 4) showed that, overall, infectious diseases had the highest ratio compared with the general population (RR = 21.6), followed by external injuries (RR = 18.8) and respiratory diseases (RR = 12.4), not considering ill-defined causes. By groups of drug use disorder, infectious diseases led excess mortality among COUD (RR = 64.6), followed by external injuries and respiratory diseases (RR = 38.4 and RR = 27.3, respectively). External injuries led excess mortality among both CUD and CAUD (RR = 12.8 and RR = 10.0, respectively), but while respiratory diseases was the second group among CUD, with an excess mortality of almost eight times that of the general population for this cause (RR = 7.8), in the case of CAUD it was infectious diseases (RR = 6.2), with respiratory (RR = 5.7) and digestive diseases (RR = 4.9) following closely.
Causes of death
DISCUSSION
Our results show higher mortality rates among individuals with concurrent cocaine and opiates use disorders, the risk of death being two times higher among this group compared to individuals with cocaine use disorder only. External injuries accounted for the highest share of deaths among the three groups, although infectious diseases showed the highest excess mortality overall. Patients with cocaine use disorder only and those with concurrent alcohol use disorder showed similar mortality rates, although they presented some differences regarding specific causes of death. The younger age group (18-34 years) had the highest mortality ratios, especially among those with cocaine and opiates use disorder, while SMR were higher among women compared to men in the three groups.
As mentioned previously, heterogeneity among cocaine users could explain the wide range of mortality rates associated with cocaine use observed in the literature [11] . Differences in the characteristics at treatment entry between the three groups of patients in the present study would support the notion of different typologies of cocaine users. Other mortality studies have also considered concomitant use of opioids, but not of alcohol [12] [13] [14] . In our study, those with cocaine and alcohol use disorder were older and there were fewer women, while fewer of those with cocaine and opiates use disorder were working compared with the other two groups. Differences in health status were also notable. Those with cocaine only and cocaine and alcohol use disorder reported better health, but were more likely to have a history of psychopathology than those with cocaine and opiates use disorder. The proportion of HIV infection, probably linked to injection use, was larger among the latter group. Similar to other studies, our results show higher mortality rates among cocaine and opioids users compared to cocaine only users [12] [13] [14] . Furthermore, in our study mortality risk among those with cocaine and opiates use disorder is two times higher compared with cocaine only, even after considering socio-demographic, health and use pattern characteristics. This excess mortality could be explained by the high share of deaths for overdose and infectious diseases observed among this group. Overdose is the specific cause accumulating more deaths in the three groups, being markedly higher among those with cocaine and opiates use disorder. Overdose has been described as the major cause of death among opioids users [4] , and it is therefore not surprising that overdose deaths among this group was outstandingly high. Infectious diseases, specifically AIDS, are the other cause of death which is significantly higher among those with cocaine and opiates use disorder, and the one showing the highest excess mortality overall.
Conversely, those with cocaine only and cocaine and alcohol use disorder show similar mortality rates. In the same way, these two groups present considerable similarities at treatment entry except for the lower proportion of women, older age and a longer period of cocaine use among those with coexisting alcohol use disorder. However, we should highlight some differences regarding causes of death that would help to establish important distinctions between these two groups. The proportion of deaths due to external injuries (including overdose, suicide and other external injuries) is higher among those with cocaine use disorder only, while the share of infectious diseases, neoplasms and digestive diseases is larger among those with cocaine and alcohol use disorder. Cocaine abstinence imposed at treatment entry leads frequently to depression which would, in turn, increase the probability of suicide during the first year. A higher risk for suicide has already been described among cocaine users linked to comorbid depression [19] [20] [21] . The burden of alcohol use on health would be manifest among those with concurrent alcohol use disorder in the higher mortality ratios for infectious and digestive diseases among this group compared to that of cocaine only, as described in other studies [22, 23] . With respect to drug overdose deaths, some non-specific causes of death such as pulmonary oedema and respiratory insufficiency, the leading cause within respiratory diseases in the three groups of our cohort, could add further to the final overdose figure. A study aimed at validating the underlying cause of death of the Mortality Register in Spain [24] found that more than 20% of the deaths registered as caused by respiratory diseases were actually due to poisoning. It is also worth mentioning the high mortality rates for ill-defined causes in our cohort. In this regard, Gotsens et al. [24] concluded that a considerable number of ill-defined causes of death were due in fact to external injuries, mainly poisoning and suicides, which would signify a further increase of these deaths in the context of our study. Even though opioid use disorder patients in our study were mainly heroin users, the widely documented increase of non-medical use of prescription opioids and its consequences, including drug overdose, prompts the need to improve data collection to favour the study and prevention of this cause of death [25] [26] [27] . As other studies have already pointed out [28] , knowledge of use patterns are important in order to target interventions to prevent drug overdose in particular subpopulations.
Comparing mortality in our cohort to that in the general population also shows that the highest excess mortality corresponds to the youngest, the only exception being women with cocaine and alcohol use disorder, due probably to the small number of young women in this group (lack of statistical power). The higher mortality observed during the first year after treatment entry in all groups can be explained because patients tend to delay seeking assistance and often reach treatment centres in a deteriorated health condition. This aspect can be extremely relevant to inform public health policies. The negative ratios obtained for neoplasm deaths could relate to the fact that in the general population this cause of death is concentrated among those aged more than 45 years, the age group showing the lowest excess mortality in our cohort. We also need to bear in mind that deaths from external injuries or infectious diseases occurring earlier in life would compete with the risk of dying of other diseases at an older age. Conversely, and contrary to the results of other studies with heroin users [29, 30] , mortality rates and hazard ratios do not differ between men and women in our cohort of substance use disorder patients. The higher SMR of women compared to men can be explained by the lower mortality rates of women in all age groups in the general population, as shown by Guitart et al. [31] .
It should also be considered that our study covers deaths occurring during a long period (from 1997 to 2011). Other studies analysing calendar-year of death in Spain have found a decrease in mortality risk in recent years among cocaine/heroin users [14] , due probably to the decrease of fatal overdoses and HIVrelated mortality following the implementation of opioid substitution therapy programmes and the wide availability of antiretroviral therapy, as well as other recent harm reduction strategies (e.g. take-home naloxone). Therefore, it is possible that differences observed among those with concurrent cocaine and opioids use disorder and the other two groups in our study would diminish if we were to consider recent years only, although looking for differences over time was not an objective of our study.
Establishing different typologies of users and examining mortality indicators and causes of death has proved to be a helpful way to shed some light on mortality associated with cocaine use. However, some other limitations should be mentioned. The groupings used in this study were defined on the basis of the patient's drug use disorder at baseline and changes regarding the drug of choice or other characteristics, such as route of administration or HIV serostatus, that might affect mortality risk were not assessed. For instance, some of the overdose deaths registered in the groups of cocaine only and cocaine and alcohol use disorder would not necessarily be cocaine overdoses, as the individual may have switched to sporadic or permanent opioid use later. Similarly, no information was collected regarding cocaine use during follow-up. Also, it could be that treatment centres differed in their assessment of substance use disorder, and this may have had an impact upon the classification of patients for our groups of use disorder; for instance, alcohol use disorder might not have been registered if cocaine use was a major concern.
Finally, our study cohort was formed by patients from public treatment centres, and this may have led to an under-representation of patients from a more advantaged socio-economic background attending private treatment services. This cohort may also lack representativeness regarding people with cocaine use disorder in the general population, with lighter forms of cocaine use disorder not seeking treatment and given the relative lack of effective treatment options. In this respect, mortality among cocaine use disorder patients in general may be overestimated in this study.
Our results indicate that excess mortality and mortality risk are significantly higher among patients with cocaine and opiates use disorder compared with the other two groups. However, our analyses have also revealed some differences between those with cocaine only and those with cocaine and alcohol use disorder regarding leading causes of death. Overdose deaths are a major concern among the three groups, and point to the need to target prevention policies for specific subpopulations of users.
